The FDA announced on Feb. 21, 2022, that Morton Grove Pharmaceuticals voluntarily recalled Dexamethasone Elixir due to failed impurity specifications. The agency stated the recall was initiated by the firm.
How to tell if you have it
- Brand: Morton Grove
- Product: Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only
- NDC: 60432-466-08
- Lot codes: UV1004, UV1005, UW1014, UW1015, UW1084
- Expiration dates: 6/22, 1/23, 7/23
The hazard
The recall was issued because higher than permissible levels of unknown impurities were found in the drug product. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Morton Grove Pharmaceuticals, Inc. has had six other recalls since Dec. 15, 2015. Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026), Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026), and Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026).